A controlled trial of cinromide.
A double-blind controlled trial of cinromide in 25 adult subjects with refractory epilepsy using the maximum tolerated dose showed that it possessed no significant antiepileptic properties.
D000293:Adolescent; D000328:Adult; D002934:Cinnamates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged
D002934:Cinnamates; C018490:cinromide